Results presented here showed patients with type 2 diabetes who used GLP-1 receptor agonists had significantly decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback